NASDAQ:CGEM
Cullinan Oncology, Inc. (CGEM)
Financials 
Technical Analysis 
;fill-opacity:1;'/%3e%3cpath%20d='M31%2018.6001V30H8V18.6001L14.1334%2022.4334L19.4999%2014L24.8669%2022.4334L31%2018.6001Z'%20fill='%23EE5432'%20style='fill:%23EE5432;fill:color(display-p3%200.9340%200.3310%200.1956);fill-opacity:1;'/%3e%3c/svg%3e){kind=small}
Premium contentWe reiterate this biopharma company focused on oncology therapies, as a TOP PICK. Pilot projects are continuing to advance and they have a growing pipeline of new prospects. It trades under book value, supporting a 14% ROE. Cash reserves are growing, while debt is retired. We recommend maintaining the stop at $8.50, looking to achieve $17.00 -- upside of 36%. Yield 0%
(Analysts’ price target is $29.00)Premium contentCGEM is a unique pharmaceutical company that collaborates with other developers and academia to develop drugs to help cancer patients. It has six on-going products in its pipeline. It trades below book value, at 6x earnings, and supports a 19% ROE. We like that it is low beta compared to the market. We recommend a stop-loss at $8.50, looking to achieve $17 — upside potential of 50%. Yield 0%
(Analysts’ price target is $28.75)- «
- ‹
- 1
- ›
- »
Cullinan Oncology, Inc. (CGEM) Frequently Asked Questions
What is Cullinan Oncology, Inc. stock symbol?
Cullinan Oncology, Inc. is a American stock, trading under the symbol CGEM (previously CGEM-Q on Stockchase) on the NASDAQ (CGEM). It is usually referred to as NASDAQ:CGEM or CGEM
Is Cullinan Oncology, Inc. a buy or a sell?
In the last year, no analyst issued a Buy, Sell, or Hold rating on CGEM (previously CGEM-Q on Stockchase) on Stockchase. Read the latest expert commentary for Cullinan Oncology, Inc..
Is Cullinan Oncology, Inc. a good investment or a top pick?
Cullinan Oncology, Inc. was recommended as a Top Pick by The Panic-Proof Portfolio (Stockchase Research) on 2023-03-09. Read the latest stock experts ratings for Cullinan Oncology, Inc..
Why is Cullinan Oncology, Inc. stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Cullinan Oncology, Inc..
Is Cullinan Oncology, Inc. worth watching?
Cullinan Oncology, Inc. is covered by Stockchase experts and is worth watching.
What is Cullinan Oncology, Inc. stock price?
On 2026-06-24, Cullinan Oncology, Inc. (CGEM) stock closed at a price of $17.65.
Our PAST TOP PICK with CGEM has triggered its stop at $8.50. To remain disciplined, we recommend covering the position at this time. This will result in a net investment loss of 27%, when combined with previous recommendations.